T) with Chronic Hepatitis B in Iraninan Patients Referred to Taleghani Hospital, Tehran]]>
T polymorphism between control and patient groups, therefore, it can be concluded that this polymorphism is not a prognostic factor for chronic hepatitis B in Iranian patients.]]>
p. 223−231
2008-2843
Vol.20/No.3
p. 232−243
2008-2843
Vol.20/No.3
p. 244−251
2008-2843
Vol.20/No.3
A polymorphism was compared in the two groups. Result: The Frequency of LT-A gene +252 for GG, GA and AA genotypes was respectively 45.5%, 47.9% and 6.6% in the case group and 49.2%, 45.8% and 5% in the control group. There was no significant difference in genotyping frequency between HCV and healthy control groups. Conclusion: In this study, we observed no significant relationship between +252 polymorphism of the LT-A gene and susceptibility to chronic hepatitis C. Therefore, polymorphism in LT-A gene is not a prognostic factor for susceptibility to chronic HCV in Iranian population.]]>
p. 252−262
2008-2843
Vol.20/No.3
p. 263−278
2008-2843
Vol.20/No.3
p. 279−291
2008-2843
Vol.20/No.3
p. 292−300
2008-2843
Vol.20/No.3
p. 301−311
2008-2843
Vol.20/No.3
p. 312−325
2008-2843
Vol.20/No.3
p. 326−330
2008-2843
Vol.20/No.3